After-Hours Action: What's Going On With Exact Sciences Stock?

Exact Sciences Corp EXAS shares are facing selling pressure after the close on Tuesday on the heels of the company's quarterly results.

What Happened: Exact Sciences said fourth-quarter revenue jumped 17% year-over-year to $553 million. Excluding COVID-19 testing, revenue was up 28% year-over-year. The company's top-line results beat average analyst estimates of $528.22 million, according to Benzinga Pro.

Screening revenue totaled $404 million and Precision Oncology revenue came in at $143 million in the fourth quarter.

Exact Sciences reported a fourth-quarter net loss of 72 cents per share, which beat estimates for a loss of 84 cents per share.

"With a strong finish in 2022 and a great start to 2023, Cologuard and Oncotype are setting the tone for an impactful year ahead," said Kevin Conroy, chairman and CEO of Exact Sciences.

Exact Sciences sees full-year 2023 revenue in a range of $2.265 billion to $2.315 billion versus estimates of $2.29 billion. Screening revenue is expected to bring in $1.66 billion to $1.69 billion, Precision Oncology revenue is expected to total $600 million to $620 million and COVID-19 testing revenue is expected to dwindle to $5 million.

Exact Sciences is a provider of cancer screening and diagnostic tests. The company will host a conference call at 5 p.m. ET to discuss these results.

See Also: Why Caesars Entertainment (CZR) Shares Are Falling During Tuesday's After-Hours Session

EXAS Price Action: Exact Sciences shares are down 2.69% after hours at $59.61, according to Benzinga Pro.

Photo: courtesy of Exact Sciences.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsGuidanceHealth CareTop StoriesAfter-Hours CenterGeneralwhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!